A novel role of HLA class I in the pathology of medulloblastoma

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Smith, Courtney ^a,c   Santi, Mariarita ^b   Rajan, Bhargavi ^a   Rushing, Elisabeth J ^d   Choi, Mi Rim ^a   Rood, Brian R ^a,c   Cornelison, Robert ^e   MacDonald, Tobey J ^a,b   Vukmanovic, Stanislav ^a,c  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN BETA2M; PROTEIN TAP2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG; CD45 ANTIGEN; HLA ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR MARKER;

ANAPLASTIC CARCINOMA; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE FUNCTION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; PHENOTYPE; PROGNOSIS; TISSUE MICROARRAY; CEREBELLUM TUMOR; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANAPLASIA; ANTIGENS, CD45; CELL LINE, TUMOR; CEREBELLAR NEOPLASMS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR MARKERS, BIOLOGICAL;

EID: 68049133332     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-59     Document Type: Article

References (63)

1. Kagi D Ledermann B Burki K Zinkernagel RM Hengartner H Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo Ann Rev Immunol 1996 14 207-232 10.1146/annurev.immunol.14.1.207
2. Rammensee H-G Chemistry of peptides associated with MHC class I and class II molecules Curr Opin Immunol 1995 7 85-96 10.1016/ 0952-7915(95)80033-6 7772286
3. Pamer E Cresswell P Mechanisms of MHC class I-restricted antigen processing Annu Rev Immunol 1998 16 323-358 10.1146/ annurev.immunol.16.1.323 9597133
4. Vukmanovic S Lilic M Santori FR Demaria S Kulig K Peptide loading of nascent MHC class I molecules Arch Immunol Ther Exp (Warsz). 2001 49 3 195-201 11478393
5. York IA Rock KL Antigen processing and presentation by the class I major histocompatibility complex Annu Rev Immunol 1996 14 369-396 10.1146/ annurev.immunol.14.1.369 8717519
6. Koopmann J-O Hammerling GJ Momburg F Generation, intracellular transport and loading of peptides associated with MHC class I molecules Curr Opin Immunol 1997 9 80-88 10.1016/S0952-7915(97)80163-X 9039771
7. Cabrera T Lopez-Nevot MA Gaforio JJ Ruiz-Cabello F Garrido F Analysis of HLA expression in human tumor tissues Cancer Immunol Immunother 2003 52 1-9 12536234
8. Chang CC Ferrone S Immune selective pressure and HLA class I antigen defects in malignant lesions Cancer Immunol Immunother 2007 56 227-236 10.1007/s00262-006-0183-1 16783578
9. Delp K Momburg F Hilmes C Huber C Seliger B Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin Bone Marrow Transplant 2000 25 S88-95 10.1038/ sj.bmt.1702363 10933198
10. Agrawal S Kishore MC MHC class I gene expression and regulation J Hematother Stem Cell Res 2000 9 795-812 10.1089/152581600750062237 11177592
11. Nacht M Dracheva T Gao Y Fujii T Chen Y Player A Akmaev V Cook B Dufault M Zhang M Molecular characteristics of non-small cell lung cancer Proc Nat Acad Sci USA 2001 98 15203-15208 65007 11752463 10.1073/ pnas.261414598
12. Kamarashev J Ferrone S Seifert B Böni R Nestle FO Burg G Dummer R TAP1 down-regulation in primary melanoma lesions: An independent marker of poor prognosis Int J Cancer 2001 95 23-28 10.1002/ 1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4 11241306
13. Saio M Teicher M Campbell G Feiner H Delgado Y Frey AB Immunocytochemical demonstration of down regulation of HLA class-I molecule expression in human metastatic breast carcinoma Clin Exp Metastasis 2004 21 243-249 10.1023/B:CLIN.0000037707.07428.ff 15387374
14. Zagzag D Salnikow K Chiriboga L Yee H Lan L Ali M Garcia R Demaria S Newcomb EW Downregulation of major histocompatibility complex antigens in invading glioma cells: Stealth invasion of the brain Lab Investig 2005 85 328-341 10.1038/labinvest.3700233 15716863
15. Ericsson C Seregard S Bartolazzi A Levitskaya E Ferrone S Kiessling R Larsson O Association of HLA class I and class II antigen expression and mortality in uveal melanoma Invest Ophthalmol Vis Sci 2001 42 2153-2156 11527924
16. Madjd Z Spendlove I Pinder SE Ellis IO Durrant LG Total loss of MHC class I is an independent indicator of good prognosis in breast cancer Int J Cancer 2005 117 248-255 10.1002/ijc.21163 15900607
17. Ramnath N Tan D Li Q Hylander B Bogner P Ryes L Ferrone S Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother 2006 55 891-899 10.1007/s00262-005-0085-7 16187081
18. Watson NFS Ramage JM Madjd Z Spendlove I Ellis IO Scholefield JH Durrant LG Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis Int J Cancer 2006 118 6-10 10.1002/ijc.21303 16003753
19. Arosa FA Santos SG Powis SJ Open conformers: The hidden face of MHC-I molecules Trends Immunol 2007 28 115-123 10.1016/j.it.2007.01.002 17261379
20. Ramalingam TS Chakrabarti A Edidin M Interaction of class I human leukocyte antigen (HLA-I) molecules with insulin receptors and its effect on the insulin-signaling cascade Mol Biol Cell 1997 8 2463-2474 25720 9398668
21. Rowley DR Dang TD McBride L Gerdes MJ Lu B Larsen M Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action Cancer Res 1995 55 781-786 7850789
22. Paczek L Czarkowska-Paczek B Korczak-Kowalska G Wierzbicki P Bartlomiejczyk I Górski A Involvement of beta2-microglobulin in CD69 expression on T cells Arch Immunol Ther Exp (Warsz). 2001 49 3 239-242 11478398
23. Nomura T Huang W Zhau H Wu D Xie Z Mimata H Zayzafoon M Young AN Marshall FF Weitzmann MN Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis Clin Cancer Res 2006 12 7294-7305 10.1158/ 1078-0432.CCR-06-2060 17189401
24. Nomura T Huang WC Seo S Zhau H Mimata H Chung LW Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma J Urol 2007 178 292-300 10.1016/ j.juro.2007.03.007 17499801
25. Bunning RA Haworth SL Cooper EH Serum beta-2-microglobulin levels in urological cancer J Urol 1979 121 624-625 86616
26. Hallgren R Nou E Lundqvist G Serum beta 2-microglobulin in patients with bronchial carcinoma and controls Cancer 1980 45 780-5 10.1002/ 1097-0142(19800215)45:4<780::AID-CNCR2820450428>3.0.CO;2-H 6153564
27. Dimopoulos MA Cabanillas F Lee JJ Swan F Fuller L Allen PK Hagemeister FB Prognostic role of serum beta 2-microglobulin in Hodgkin's disease J Clin Oncol 1993 11 1108-11 8501496
28. Sadamori N Mine M Hakariya S Ichiba M Kawachi T Itoyama T Nakamura H Tomonaga M Hayashi K Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia Leukemia 1995 9 594-547 7723390
29. Rasmuson T Grankvist K Ljungberg B Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma Acta Oncol 1996 35 479-482 10.3109/02841869609109926 8695165
30. Mavridis AK Tsiara S Makis A Chaidos A Christou L Seferiadis K Bourantas KL Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia J Exp Clin Cancer Res 1998 17 445-448 10089066
31. Rajkumar SV Greipp PR Prognostic factors in multiple myeloma Hematol Oncol Clin North Am 1999 13 1295-1314 10.1016/S0889-8588(05)70128-3 10626152
32. Abdul M Hoosein N Changes in beta-2 microglobulin expression in prostate cancer Urol Oncol 2000 5 168-172 10.1016/S1078-1439(00)00063-6 10869961
33. Roberts RO Lynch CF Jones MP Hart MN Medulloblastoma: A population-based study of 532 cases Journal of Neuropathology and Experimental Neurology 1991 50 2 134-44 10.1097/00005072-199103000-00005
34. Packer RJ Childhood medulloblastoma: Progress and future challenges Brain Dev 1999 21 75-81 10.1016/S0387-7604(98)00085-0 10206522
35. MacDonald TJ Brown KM LaFleur B Peterson K Lawlor C Chen Y Packer RJ Cogen PH Stephan DA Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease Nat Genet 2001 29 143-152 10.1038/ng731 11544480
36. Abouantoun TJ Macdonald TJ Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor Mol Cancer Ther 2009 19417143
37. Kononen J Bubendorf L Kallioniemi A Bärlund M Schraml P Leighton S Torhorst J Mihatsch MJ Sauter G Kallioniemi OP Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 1998 4 844-847 10.1038/nm0798-844 9662379
38. Perosa F Luccarelli G Prete M Favoino E Ferrone S Dammacco F Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide J Immunol 2003 171 1918-1926 12902494
39. Albers A Abe K Hunt J Wang J Lopez-Albaitero A Schaefer C Gooding W Whiteside TL Ferrone S DeLeo A Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck Cancer Res 2005 65 11146-11455 10.1158/0008-5472.CAN-05-0772 16322265
40. Maziarz RT Fraser J Strominger JL Burakoff SJ The human HLA-specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db Immunogenetics 1986 24 206-208 2428745
41. Jefferies WA MacPherson GG Expression of the W6/32 HLA epitope by cells of rat, mouse, human and other species: Critical dependence on the interaction of specific MHC heavy chains with human or bovine beta 2-microglobulin Eur J Immunol 1987 17 1257-1263 10.1002/eji.1830170907 2443365
42. Tanabe M Sekimata M Ferrone S Takiguchi M Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain J Immunol 1992 148 3202-2309 1374450
43. Adams EJ Green JA Clark AH Youngson JH Comparison of different scoring systems for immunohistochemical staining J Clin Pathol 1999 52 75-7 501013 10343618 10.1136/jcp.52.1.75
44. Voigt A Zintl F Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells Med Pediatr Oncol 2003 40 205-13 10.1002/mpo.10250 12555246
45. Messi E Florian MC Caccia C Zanisi M Maggi R Retinoic acid reduces human neuroblastoma cell migration and invasiveness: Effects on DCX, LIS1, neurofilaments-68 and vimentin expression BMC Cancer 2008 8 30 2254429 18230156 10.1186/1471-2407-8-30
46. Bodey B Bodey BJ Siegel SE Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors Mod Pathol 1995 8 333-338 7617661
47. Raffaghello L Nozza P Morandi F Camoriano M Wang X Garrè ML Cama A Basso G Ferrone S Gambini C Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma Cancer Res 2007 67 5471-5478 10.1158/ 0008-5472.CAN-06-4735 17545629
48. Perry A Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain? Adv Anat Pathol 2002 9 345-350 10.1097/00125480-200211000-00003 12409643
49. Ellison D Classifying the medulloblastoma: Insights from morphology and molecular genetics Neuropathol Appl Neurobiol 2002 28 257-282 10.1046/ j.1365-2990.2002.00419.x 12175339
50. Stearns D Chaudhry A Abel TW Burger PC Dang CV Eberhart CG c-Myc overexpression causes anaplasia in medulloblastoma Cancer Res 2006 66 673-681 10.1158/0008-5472.CAN-05-1580 16423996
51. Gulino A Arcella A Giangaspero F Pathological and molecular heterogeneity of medulloblastoma Curr Opin Oncol 2008 20 668-675 10.1097/ CCO.0b013e32831369f4 18841049
52. Dudley DT Pang L Decker SJ Bridges AJ Saltiel AR A synthetic inhibitor of the mitogen-activated protein kinase cascade Proc Natl Acad Sci USA 1995 92 7686-7689 41210 7644477 10.1073/pnas.92.17.7686
53. Geppert TD Wacholtz MC Patel SS Lightfoot E Lipsky PE Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules J Immunol 1989 142 3763-3772 2469725
54. Skov S Bregenholt S Claesson MH MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis J Immunol 1997 158 3189-3196 9120273
55. Gur H el-Zaatari F Geppert TD Wacholtz MC Taurog JD Lipsky PE Analysis of T cell signaling by class I MHC molecules: The cytoplasmic domain is not required for signal transduction J Exp Med 1990 172 1267-1270 2188606 2212953 10.1084/jem.172.4.1267
56. Smits A van Grieken D Hartman M Lendahl U Funa K Nister M Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblasdtomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal deviation Lab Investig 1996 74 188-198 8569181
57. Patti R Reddy CD Geoerger B Grotzer MA Raghunath M Sutton LN Phillips PC Autocrine secreted insulin-like growth factor-I stimulates MAP kinase-dependent mitogenic effects in human primitive neuroectodermal tumor/medul.loblastoma Int J Oncol 2000 16 577-584 10675492
58. Bodey B Kaiser HE Siegel SE Epidermal growth factor receptor (EGFR) expression in childhood brain tumors In vivo 2005 19 931-941 16097449
59. Schuller U Koch A Hartmann W Garre ML Goodyer CG Cama A Sorensen N Wiestler OD Pietsch T Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas Int J Cancer 2005 117 82-89 10.1002/ijc.21116 15880586
60. Wlodarski P Grajkowska W Lojek M Rainko K Józwiak J Activation of Akt and Erk pathways in medulloblastoma Folia Neuropathol 2006 44 214-220 17039417
61. Van Kanegan MJ Adams DG Wadzinski BE Strack S Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt J Biol Chem 2005 280 36029-36036 10.1074/jbc.M506986200 16129692
62. Dunn KL Espino PS Drobic B He S Davie JR The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling Biochem Cell Biol 2005 83 1-14 10.1139/o04-121 15746962
63. Yoon S Seger R The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions Growth Factors 2006 24 21-44 10.1080/02699050500284218 16393692